Tapewire

Nasdaq · USD

QURE

uniQure N.V.

Export transactions ↓
Tapewire entity
4162
SEC CIK
0001590560
Parsed reports
431

Last 12 months

Inside the activity.

0 purchase rows · 57 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202500
Jan 202604
Feb 202602
Mar 202608
Apr 202600
May 202602
Jun 2026033
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2025 Filed Jun 13, 2025 21:01 UTC
Kaye JackDirector
GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000316 · edgar.xml · nonDerivative · entry 1

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,551

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:27 UTC GrantStock Option (Right to Buy) · Derivative 15,630 $0.00 Strike: $16.22 $0.00
Disclosure

SEC source: 0000904454-25-000305 · edgar.xml · derivative · entry 2

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Ordinary Shares · 15,630 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:27 UTC GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000305 · edgar.xml · nonDerivative · entry 1

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,302

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:44 UTC GrantStock Option (Right to Buy) · Derivative 15,630 $0.00 Strike: $16.22 $0.00
Disclosure

SEC source: 0000904454-25-000309 · edgar.xml · derivative · entry 2

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Ordinary Shares · 15,630 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:44 UTC GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000309 · edgar.xml · nonDerivative · entry 1

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,809

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:55 UTC GrantStock Option (Right to Buy) · Derivative 15,630 $0.00 Strike: $16.22 $0.00
Disclosure

SEC source: 0000904454-25-000314 · edgar.xml · derivative · entry 2

Jacques Rachelle Suzanne · CIK 0001772610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Ordinary Shares · 15,630 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:55 UTC GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000314 · edgar.xml · nonDerivative · entry 1

Jacques Rachelle Suzanne · CIK 0001772610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,458

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:50 UTC
Gut RobertDirector
GrantStock Option (Right to Buy) · Derivative 15,630 $0.00 Strike: $16.22 $0.00
Disclosure

SEC source: 0000904454-25-000311 · edgar.xml · derivative · entry 2

Gut Robert · CIK 0001716268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Ordinary Shares · 15,630 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:50 UTC
Gut RobertDirector
GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000311 · edgar.xml · nonDerivative · entry 1

Gut Robert · CIK 0001716268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,215

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:37 UTC GrantStock Option (Right to Buy) · Derivative 15,630 $0.00 Strike: $16.22 $0.00
Disclosure

SEC source: 0000904454-25-000307 · edgar.xml · derivative · entry 2

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Ordinary Shares · 15,630 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:37 UTC GrantOrdinary Shares 7,970 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000307 · edgar.xml · nonDerivative · entry 1

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,806

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 22:32 UTC
Kapusta Matthew CDirector · CEO, Managing Director
SaleOrdinary Shares 28,341 $10.29 $291,628.89
Disclosure

SEC source: 0000904454-25-000182 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 651,454

F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number os shares sold at each sparate price within the range set forth in the footnote.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 22:28 UTC
Abi-Saab WalidChief Medical Officer
SaleOrdinary Shares 1,350 $10.29 $13,891.50
Disclosure

SEC source: 0000904454-25-000180 · edgar.xml · nonDerivative · entry 2

Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,903

F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 22:25 UTC
KLEMT CHRISTIANChief Financial Officer
SaleOrdinary Shares 10,438 $10.29 $107,407.02
Disclosure

SEC source: 0000904454-25-000178 · edgar.xml · nonDerivative · entry 2

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,730

F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 22:21 UTC
Potts JeannetteChief Legal Officer
SaleOrdinary Shares 7,076 $10.29 $72,812.04
Disclosure

SEC source: 0000904454-25-000176 · edgar.xml · nonDerivative · entry 2

Potts Jeannette · CIK 0001814693 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,743

F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:32 UTC
Kapusta Matthew CDirector · CEO, Managing Director
GrantStock Option (Right to Buy) · Derivative 171,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0000904454-25-000182 · edgar.xml · derivative · entry 3

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,000

Underlying: Ordinary Shares · 171,000 shares

Expires 2025-03-03

F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:32 UTC
Kapusta Matthew CDirector · CEO, Managing Director
GrantOrdinary Shares 99,000 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000182 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 679,795

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:28 UTC
Abi-Saab WalidChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 66,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0000904454-25-000180 · edgar.xml · derivative · entry 3

Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: Ordinary Shares · 66,000 shares

Expires 2035-03-03

F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:28 UTC
Abi-Saab WalidChief Medical Officer
GrantOrdinary Shares 38,000 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000180 · edgar.xml · nonDerivative · entry 1

Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,253

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:25 UTC
KLEMT CHRISTIANChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 126,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0000904454-25-000178 · edgar.xml · derivative · entry 3

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,000

Underlying: Ordinary Shares · 126,000 shares

Expires 2035-03-03

F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:25 UTC
KLEMT CHRISTIANChief Financial Officer
GrantOrdinary Shares 73,000 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000178 · edgar.xml · nonDerivative · entry 1

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,168

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:21 UTC
Potts JeannetteChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0000904454-25-000176 · edgar.xml · derivative · entry 3

Potts Jeannette · CIK 0001814693 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires 2035-03-03

F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:21 UTC
Potts JeannetteChief Legal Officer
GrantOrdinary Shares 35,000 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000176 · edgar.xml · nonDerivative · entry 1

Potts Jeannette · CIK 0001814693 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,819

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2025 Filed Feb 28, 2025 00:33 UTC
Kapusta Matthew CDirector · CEO, Managing Director
SaleOrdinary Shares 6,717 $11.32 $76,036.44
Disclosure

SEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 3

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,795

F4 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F4 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.28 to $11.42. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 27, 2025 Filed Feb 28, 2025 00:29 UTC
KLEMT CHRISTIANChief Financial Officer
SaleOrdinary Shares 2,916 $11.32 $33,009.12
Disclosure

SEC source: 0000904454-25-000165 · edgar.xml · nonDerivative · entry 3

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,168

F4 · security: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F4 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F4 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.28 to $11.41. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 00:33 UTC
Kapusta Matthew CDirector · CEO, Managing Director
GrantOrdinary Shares 16,324 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,512

F3 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on February 26, 2025 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 00:29 UTC
KLEMT CHRISTIANChief Financial Officer
GrantOrdinary Shares 5,712 $0.00 $0.00
Disclosure

SEC source: 0000904454-25-000165 · edgar.xml · nonDerivative · entry 2

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,084

F3 · security: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on February 26, 2025 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share.

F3 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on February 26, 2025 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
February 25, 2025 Filed Feb 28, 2025 00:33 UTC
Kapusta Matthew CDirector · CEO, Managing Director
SaleOrdinary Shares 26,727 $10.70 $285,978.90
Disclosure

SEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 571,188

F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.56 to $11.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 25, 2025 Filed Feb 28, 2025 00:29 UTC
KLEMT CHRISTIANChief Financial Officer
SaleOrdinary Shares 14,341 $10.70 $153,448.70
Disclosure

SEC source: 0000904454-25-000165 · edgar.xml · nonDerivative · entry 1

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,372

F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.56 to $11.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 21:54 UTC
Kapusta Matthew CDirector · CEO, Managing Director
Exercise / conversionStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $14.71 $0.00
Disclosure

SEC source: 0000904454-24-000650 · edgar.xml · derivative · entry 3

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 100,000 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025.

F3 · derivative.exercise_date: The Stock Option vested 25% on January 2, 2016 and 6.25% quarterly thereafter.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 21:54 UTC
Kapusta Matthew CDirector · CEO, Managing Director
SaleOrdinary Shares 100,000 $15.03 $1,503,000.00
Disclosure

SEC source: 0000904454-24-000650 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 597,915

F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.14. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 21:54 UTC
Kapusta Matthew CDirector · CEO, Managing Director
Exercise / conversionOrdinary Shares 100,000 $14.71 $1,471,000.00
Disclosure

SEC source: 0000904454-24-000650 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 697,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:03 UTC
Kapusta Matthew CDirector · CEO, Managing Director
SaleOrdinary Shares 3,418 $7.63 $26,079.34
Disclosure

SEC source: 0000904454-24-000644 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 597,915

F2 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 21:54 UTC
KLEMT CHRISTIANChief Financial Officer
SaleOrdinary Shares 1,796 $7.55 $13,559.80
Disclosure

SEC source: 0000904454-24-000642 · edgar.xml · nonDerivative · entry 2

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,713

F2 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.48 to $7.56. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 08, 2024 Filed Dec 10, 2024 22:03 UTC
Kapusta Matthew CDirector · CEO, Managing Director
GrantOrdinary Shares 10,494 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000644 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 601,333

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on December 8, 2024 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
December 08, 2024 Filed Dec 10, 2024 21:54 UTC
KLEMT CHRISTIANChief Financial Officer
GrantOrdinary Shares 3,672 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000642 · edgar.xml · nonDerivative · entry 1

KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,509

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on December 8, 2024 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 20:21 UTC
Abi-Saab WalidChief Medical Officer
SaleOrdinary Shares 1,447 $4.36 $6,308.92
Disclosure

SEC source: 0000904454-24-000409 · edgar.xml · nonDerivative · entry 1

Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,253

F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.35 to $4.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:00 UTC GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000397 · edgar.xml · derivative · entry 2

POST LEONARD E · CIK 0001235862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:00 UTC GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000397 · edgar.xml · nonDerivative · entry 1

POST LEONARD E · CIK 0001235862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,079

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:04 UTC
Kaye JackDirector
GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000399 · edgar.xml · derivative · entry 2

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:04 UTC
Kaye JackDirector
GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000399 · edgar.xml · nonDerivative · entry 1

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,581

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:10 UTC GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000403 · edgar.xml · derivative · entry 2

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:10 UTC GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000403 · edgar.xml · nonDerivative · entry 1

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,332

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:07 UTC GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000401 · edgar.xml · derivative · entry 2

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:07 UTC GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000401 · edgar.xml · nonDerivative · entry 1

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,839

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:19 UTC
Gut RobertDirector
GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000407 · edgar.xml · derivative · entry 2

Gut Robert · CIK 0001716268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:19 UTC
Gut RobertDirector
GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000407 · edgar.xml · nonDerivative · entry 1

Gut Robert · CIK 0001716268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,245

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:14 UTC GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000405 · edgar.xml · derivative · entry 2

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 21:14 UTC GrantOrdinary Shares 8,080 $0.00 $0.00
Disclosure

SEC source: 0000904454-24-000405 · edgar.xml · nonDerivative · entry 1

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,836

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
June 19, 2024 Filed Jun 21, 2024 20:57 UTC GrantStock Option (Right to Buy) · Derivative 15,840 $0.00 Strike: $4.57 $0.00
Disclosure

SEC source: 0000904454-24-000395 · edgar.xml · derivative · entry 2

Jacques Rachelle Suzanne · CIK 0001772610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

Underlying: Ordinary Shares · 15,840 shares

Expires 2034-06-19

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.